Trial Profile
A prospective study to evaluate the efficacy of pregabalin for chemotherapy-induced peripheral nueralgia.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuralgia
- Focus Therapeutic Use
- 30 May 2017 Status changed from recruiting to discontinued.
- 09 Jun 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 03 Jun 2011 New trial record